logo

Assessment of Drug Therapy for Huntington Disease: Study Design and Treatment Protocols

   

Added on  2023-06-15

10 Pages436 Words110 Views
 | 
 | 
 | 
Study design
Presentation
Assessment of Drug Therapy for Huntington Disease: Study Design and Treatment Protocols_1

Objectives of study
Main objective is assessment of drug of PBT2
and Beraxotene on improvement of the motor
function and neuron survivability
Primary outcomes;
Drug therapy feasibility
Effectiveness and safety of drug therapy
Change from baseline to end of 3 years evaluation
on total functional capacity
Assessment of Drug Therapy for Huntington Disease: Study Design and Treatment Protocols_2

Primary evaluation based on recruitment,
adherence and retention rates
Secondary otucomes measure of motor
function assessed using UHDRS TMS
Specific assessment on dysarthria, tongue
protrusion , bradykinesia and luria rigidity of
arms functionality
Cognitive assessment will be assessed using
verbal fluency on tests using MMSE
Assessment of Drug Therapy for Huntington Disease: Study Design and Treatment Protocols_3

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
Study Design and Data Analysis for Drug Therapy in Huntington Disease Patients
|5
|1617
|491

Critical Review of Glucosamine and Chondroitin for Knee Osteoarthritis
|5
|1033
|127

Quantitative Research on Non-Therapeutic Intervention for Fibromyalgia Patients
|13
|4544
|47

Evaluating the Long-term Utilization of NRT in Smoking Cessation
|7
|1766
|159

Decision Making for Dementia Patients
|12
|3644
|88

Critical Appraisal of Quantitative and Qualitative Articles on Healthcare
|13
|3911
|102